Loading data
ARBENasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.03 m USD | 768 k USD | 1.47 m USD | 3.52 m USD | 2.25 m USD |
| Cost of revenue | 1.83 m USD | 1.55 m USD | 1.51 m USD | 1.28 m USD | 1.44 m USD |
| Gross profit | -802 k USD | -785 k USD | -38 k USD | 2.23 m USD | 809 k USD |
| Research and development expense | 34.82 m USD | 35.09 m USD | 34.08 m USD | 36.73 m USD | 28.56 m USD |
| Operating profit | -48.21 m USD | -49.65 m USD | -46.89 m USD | -47.73 m USD | -33.28 m USD |
| Profit before tax | 46.42 m USD | 49.32 m USD | 43.5 m USD | 40.49 m USD | 58.09 m USD |
| Net income (reported basis) | -46.42 m USD | -49.32 m USD | -43.5 m USD | -40.49 m USD | -58.09 m USD |
| Net income attributable to common shareholders | -46.42 m USD | -49.32 m USD | -43.5 m USD | -40.49 m USD | — |
| Basic earnings per share | -0.42 USD/share | -0.61 USD/share | -0.6 USD/share | -0.64 USD/share | -2.64 USD/share |
| Diluted earnings per share | -0.42 USD/share | -0.61 USD/share | -0.61 USD/share | -0.66 USD/share | -2.64 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.